arrow
N

Nick J. Reynolds

newcastle university
H指数:60
被引数:1.3万

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Risks of tuberculosis, meningitis, candidiasis, and fungal infections among patients receiving systemic treatments for psoriasis: a nationwide cohort study from BADBIR data

银屑病患者接受系统性治疗后发生结核病、脑膜炎、念珠菌病和真菌感染的风险:一项基于BADBIR数据的全国队列研究

2026-09-150
OAAI
Differential BET protein recruitment to IL6 and IL8 promoters and suppression of inflammatory and cell cycle genes by BET inhibitor in keratinocytes

角化细胞中BET蛋白对IL6和IL8启动子的差异性募集以及BET抑制剂对炎症和细胞周期基因的抑制作用

2026-09-130
PRE
P127 Impact of minimal disease activity on quality of life in patients with atopic eczema: results from the UK-Irish Atopic eczema Systemic TherApy Register (A-STAR)

P127 最小疾病活动度对特应性湿疹患者生活质量的影响:来自英国-爱尔兰特应性湿疹系统性治疗登记系统(A-STAR)的结果

2026-06-260
OAAI
Evaluation of a Therapeutic Drug Monitoring Strategy for Adalimumab in Psoriasis: A Prospective Pharmacokinetic-Pharmacodynamic Study

评价阿达木单抗在银屑病中的治疗药物监测策略:一项前瞻性药代动力学-药效学研究

2026-04-300
OAAI
Transcriptomic profiling and machine learning uncover gene signatures of psoriasis endotypes and disease severity

转录组分析和机器学习揭示银屑病内型和疾病严重程度的基因特征

2026-01-210
OAAI
Baseline characteristics of atopic eczema patients enrolled in seven European registries united in the TREatment of ATopic eczema (TREAT) registry taskforce

纳入TREAT(治疗特应性湿疹)注册研究任务组的七项欧洲注册研究中特应性湿疹患者的基线特征

2025-08-200
OAAI
(P002) Predicting psoriasis biologic drug discontinuation: an explainable machine learning approach applying British Association of Dermatologists Biologics and Immunomodulators Register data

(P002) 预测银屑病生物制剂药物停用:一种基于英国皮肤科医师学会生物制剂和免疫调节剂登记数据的可解释机器学习方法

2025-07-010
OA
Asthma control in patients receiving systemic therapy for atopic eczema: results from the UK Atopic eczema Systemic TherApy Register (A-STAR)

特应性湿疹系统性治疗患者的哮喘控制:来自英国特应性湿疹系统性治疗登记系统(A-STAR)的结果

2025-07-010
OA
Evaluating changes in baseline characteristics and drug-utilization pattern in patients with moderate-to-severe psoriasis: findings from the British Association of Dermatologists Biologics and Immunomodulators Register (BADBIR) cohort

评估中度至重度银屑病患者基线特征和药物使用模式的变化:英国皮肤科医师生物制剂和免疫调节剂登记研究(BADBIR)队列的研究结果

2025-07-012
OAAI
Association between novel systemic immunomodulatory medications and achievement of super response in patients with moderate-to-severe atopic eczema: results from the UK-Irish Atopic Eczema Systemic Therapy Register (A-STAR)

新型全身免疫调节药物与中重度特应性湿疹患者实现超反应之间的关联:来自英国-爱尔兰特应性湿疹全身治疗登记系统(A-STAR)的结果

2025-07-010
OAAI
The UK-Irish Atopic Eczema Systemic Therapy Register (A-STAR): a pilot descriptive analysis of healthcare resource use, costs and health-related quality of life in patients on systemic treatments for atopic eczema

英国-爱尔兰特应性湿疹系统性疗法登记系统(A-STAR):对接受特应性湿疹系统性治疗的患者医疗资源使用、成本和健康相关生活质量的一项试点描述性分析

2025-07-010
OAAI
P002 Predicting psoriasis biologic drug discontinuation: an explainable machine learning approach applying British Association of Dermatologists Biologics and Immunomodulators Register data

P002 预测银屑病生物制剂停药:一种基于英国皮肤科医师协会生物制剂和免疫调节剂登记数据的可解释机器学习方法

2025-06-270
PRE